The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
28
No.
46
December 13, 2002Dec 13, 2002
Free
DOWNLOAD THE PDF

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

Texas Oncology Designated Aranesp As Preferred Treatment

After Congressional Inquiry, NCI Posts Ambiguous Statement On Abortion And Breast Cancer Risk

Foundation Gives $1 Million To UPCI For Genetics Chair

Funding Opportunities

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account